858 Therapeutics
858 Therapeutics is a biotechnology company focused on discovering small molecule therapeutics for novel targets in oncology and immunology. The company emphasizes innovative approaches in synthetic lethality, innate immunity, and RNA modulation. Its lead program is a PARG inhibitor currently in early clinical development.
Domain
8five8tx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$50.0M
Founded
2018
Tech Stack (5 technologies)
Frequently Asked Questions
What technologies does 858 Therapeutics use?+
858 Therapeutics uses 5 technologies including Google Analytics, Google Tag Manager, Firebase.
What industry is 858 Therapeutics in?+
858 Therapeutics operates in the Biotechnology industry.
Where is 858 Therapeutics based?+
858 Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026